{"text": "TITLE:\n      Are There Protective Effects of Antioxidants, Calcium Channel Blocker and Angiotensin Receptor Blocker Against Extracorporeal Shockwaves Lithotripsy Induced Renal Injury?\nSUMMARY:\n      This study will be conducted to evaluate the protective effects and mechanisms of\n      antioxidants (vitamins A, C, E and Selenium), calcium channel blocker (Verapamil) and\n      angiotensin receptor blocker (Lozartan) against shock wave induced renal injuries.\nDETAILED DESCRIPTION:\n      The protective effect will be evaluated via estimation of the changes in renal tubular\n      enzyme (NGAL) and detection of albumen levels in urine. The mechanisms of protection will be\n      investigated by estimation of renal perfusion and functional changes using dynamic MRI.\nELIGIBILITY CRITERIA:\n      Inclusion Criteria:\n          1. Well functioning kidney (serum creatinine <1.2 mg/dl).\n          2. Solitary renal stone.\n          3. Size: 25 mm or less in the largest diameter.\n        Exclusion Criteria:\n          1. Contraindications to ESWL\n          2. Previous surgical treatment of renal stones.\n          3. Congenital renal anomalies.\n          4. Pediatric patients (age <18 years).\n          5. Patients with Diabetes or hypertension\n", "cuis": "C0006684 C3536851 C0003402 C0003018 C0523498 C0003009 C0373546 C0023878 C3263722 C3263723 C0022646 C0042075 C1328018 C2936586 C3850102 C3179493 C1552616 C1706244 C0947630 C0220825 C0006684 C0872271 C0358701 C0573229 C0003402 C0042523 C0280858 C1527129 C0042890 C0016410 C0310589 C3540032 C0373721 C0521939 C0003018 C0003009 C3263723 C0036974 C0022646 C1979715 C0126174 C0678257 C0033080 C1521941 C0680844 C0587341 C0022646 C0220825 C0042036 C0591833 C1545588 C1511790 C0194133 C0680844 C0587341 C0562230 C0243161 C0013893 C0243161 C0201976 C0600061 C0858112 C0428282 C0022646 C0227665 C0022650 C1458136 C0392525 C1879945 C0243161 C0015359 C1301624 C1547316 C3714732 C0543467 C2363849 C0022650 C0392525 C1458136 C0022646 C3640029 C0876889 C0587599 C1951312 C0220644 C0020538 C1963138 C1696708 C2748577 C0947663 C0011847 C0011849 C0011860 C1550655 C1578485 C1578486 C2360836 C2360838 C2360840 ", "concepts": "Calcium Channel Blockers, Calcium Channel Blocker [EPC], Antioxidants, Angiotensin, Angiotensin I, Angiotensin 2, Angiotensin II, Lithotripsy, Injury, Injury, Renal, Renal, Therex, ADP Receptor Blockers, CCR5 Receptor Blockers, Cryoprotective Effects summary, summary study, Evaluate calcium channel blocker, sodium channel blocker, Atenolol+calcium channel blocker, calcium channel blocker overdose, antioxidants, Verapamil, R Verapamil, Verapamil SR, vitamins, m vitamins, d vitamins, Vitamins, Selenium, Selenium angiotensin, 2 angiotensin, injuries, shock, renal, H2 receptor blockers, lozartan description, prescription, prescription estimation, Hb estimation, renal, Evaluated urine, Murine, Protection, Detection renal perfusion, estimation, Hb estimation, hand function criteria, Eligibility Criteria serum creatinine test, serum creatinine level, serum creatine, low serum creatinine, kidneys, kidneys renal stones, Renal stone, Renal stones Size Criteria eswl, contraindication, Contraindication, Contraindication surgical treatment, Non-surgical treatment, renal stone, Renal stones, Renal stone renal, Congenital VT Pediatric, Pediatrics, Pediatrix, Pediatric HD hypertension, Hypertension, Prehypertensions, No hypertension, hypertensin, Diabetes, Diabetes, diabetes, Patient, Patient, Patient, Patient, Patient, Patient "}
